CFTR and cystic fibrosis: More recently, the widespread introduction of the CFTR modulator combination of Elexacaftor / Tezacaftor / Ivacaftor (ETI) (Kaftrio® / Trikafta®, Vertex Pharmaceuticals) in 2019 has changed the landscape of CF treatment.